Rapamycin, competing with other rapalogs, activates TRPM8 via directly binding to a novel binding site, which results in providing new insights into the mechanisms of TRPM8 activation.
Neurodegenerative diseases are marked by the progressive and irreversible decline of neuron function within specific brain regions, including Alzheimer's, ...